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Strand-speciﬁc microarrayAntisense transcription is pervasive among biological systems and one of the products of antisense transcription
is natural antisense transcripts (NATs). Emerging evidences suggest that they are key regulators of gene
expression. With the discovery of NATs in Plasmodium falciparum, it has been suggested that these might also
be playing regulatory roles in this parasite. However, all the reports describing the diversity of NATs have
come from parasites in culture condition except for a recent study published by us. In order to explore the
in vivo diversity of NATs in P. falciparum clinical isolates, we performed a whole genome expression proﬁling
using a strand-speciﬁc 244 K microarray that contains probes for both sense and antisense transcripts. In this
report, we describe the experimental procedure and analysis thereof of the microarray data published recently
in Gene Expression Omnibus (GEO) under accession number GSE44921. This published data provide a wealth
of information about the prevalence of NATs in P. falciparum clinical isolates from patients with diverse malaria
related disease conditions. Supplementary information about the description and interpretation of the data can
be found in a recent publication by Subudhi et al. in Experimental Parasitology (2014).
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).ax: +91 1596 244183.
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Consent Written informed consent were obtained from
patients before study entry
Sample source location Bikaner, Rajasthan, India, geographical coordinates,
Latitude- 28.0167° N and Longitude- 73.3119° EDirect link to deposited data
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE44921Experimental design, materials and methods
The 244 K custom P. falciparum array designing
The 244K P. falciparum customarraywas designedon anAgilent plat-
form using the RightDesign (Genotypic Technology Pvt. Ltd., Bangalore,
India) probe design workﬂow. This workﬂow chooses the best
probe(s) for a transcript by balancing several criteria: GC content,
sequence complexity, cross-hybridization potential and secondaryhe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Table 1
Types of transcript detected in complicated and uncomplicated malaria isolates.
Type of transcripts Complicated
isolates
Uncomplicated
isolates
Only antisense transcripts 34 35
Only sense transcripts 677 359
Both sense and antisense transcripts 736 302
Total number of antisense transcripts detected 797
Antisense transcripts from Protein coding genes 788
Antisense transcripts from rRNA coding genes 7
Antisense transcripts from Non protein coding genes 2
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These probes designed in both sense and antisense orientations (sense
and antisense probes) representing P. falciparum 3D7 transcript se-
quences from PlasmoDBv5.3 [1,2], P. falciparum EST sequences available
in the NCBI EST database (2007), apicoplast sequences of P. falciparum
[10] and apicoplast sequences of Plasmodium vivax [7,8]. Annotations of
all the probes were updated again according to PlasmoDBv8.2 and
NCBI database (2012). Probeswere designedwith an average of 8 per se-
quence in both sense and antisense direction. Detailed description about
the array can be found in [9]. Array details including the array design,
array information such as feature number, Probe ID, probes sequence,
target gene identiﬁer ID and target gene description have been submit-
ted to Gene Expression Omnibus (GEO) and available under GEO acces-
sion number (GPL16484). Additionally, here we also give the
information about each probe orientation in the array (Supplemen-
tary Table S1).
Sample collection and processing
Venous blood samples (~5 ml) were collected from P. falciparum
infected adult patients (n = 11) on in informed consent admitted to
S. P. Medical College, Bikaner, India. Infection with P. falciparum was
conﬁrmed by slide microscopy and RDTs (OptiMal test; Diamed AG,
Cressier sur Morat, Switzerland, Falcivax; Zephyr Biomedical System,
Goa, India) in the hospital. The patients exhibited symptoms which
were categorized as either complicated (n = 9) or uncomplicated
malaria (n=2) [11]. All other laboratory investigation were performed
to rule out possibility of any other possible cause for symptoms exhibit-
ed as described elsewhere [3,4]. Infected and uninfected RBCswere sep-
arated from peripheral blood mononuclear cells by subjecting the
collected blood to a density gradient-based centrifugation and separa-
tion according to manufacturer's instructions (Histopaque 1077,
Sigma Aldrich, USA). The RBCs and PBMCs fractions were washed
twice with phosphate-buffered saline and lysed with four volume of
TriReagent (SigmaAldrich, USA). The lysed fractionswere stored imme-
diately in−80 °C deep freezers till further processing. Samples were
shipped to BITS, Pilani, Rajasthan, in cold chain where RNA and DNA
isolation from samples were carried out. DNA from samples were used
to conﬁrm the infection of only P. falciparum by performing 18 s
rRNA-based multiplex PCR [6] and 28 s rRNA-based nested PCR [5].
RNA quality control checking, labeling, hybridization and scanning
The isolated total RNA from each sample was processed on denatur-
ing agarose gels to assess its integrity. Total RNA integrity was also
assessed using RNA 6000 Nano Lab Chip on the 2100 Bioanalyzer
(Agilent, Palo Alto, CA) followingmanufacturer's instructions. RNApuri-
ty was assessed using the NanoDrop ND-1000 UV-Vis Spectrophotome-
ter (Nanodrop Technologies, Rockland, USA). Complicated (n = 9)
and uncomplicated (n= 2) malaria parasite RNA samples were pooled
in equimolar amount separately. The pooled complicated and uncom-
plicated malaria parasite RNA sample were ampliﬁed and labeled in
presence of Cyanine-5 CTP and Cyanine-3 CTP, respectively, using Low
RNA Input Fluorescent Linear Ampliﬁcation Kit (Agilent Technologies)
as described by the manufacturer to use in a two color microarray
hybridization experiment. This resulted in production of ampliﬁed and
labeled cRNA, which was cleaned and quality assessed for yields and
speciﬁc activity. For hybridization purpose, 1500 ng of each Cy-3 and
Cy-5 labeled cRNA samples was mixed, fragmented and hybridized to
the 244 K array with Gene Expression Hybridization Kit (Agilent Tech-
nologies, Part No. 5188-5242). Hybridizationwas carried out in Agilent's
Surehyb Chambers at 65 °C for 16 h. The hybridized slides were washed
using Gene Expression wash buffers (Agilent Technologies, Part No.
5188-5327) and scanned using the Agilent Microarray Scanner (Agilent,
Palo Alto, CA, G Model G2565BA) at 5 μm resolution. Data from images
were extracted using Feature Extraction software (Agilent Technologies).Data analysis
The data from Red channel (complicated) and Green channel
(uncomplicated) were analyzed separately. For each spot, the raw sig-
nal intensity and the background signal intensity were obtained from
the raw data ﬁles. Ratio was calculated by dividing the raw signal inten-
sity with the background signal intensity for each of the probes. Based
on the probe orientation, the probes were classiﬁed as sense and anti-
sense probes. Probes representing the sense and antisense transcripts
were ﬁltered by considering signal intensity, which was ≥ twice the
background intensity for complicated cases and ≥1.5 times for uncom-
plicated cases. The probe-based data were converted to gene-based
data. For genes represented with multiple probes, median of raw signal
intensity and background signal intensity was considered. Genes were
further classiﬁed based on the type of transcripts they produced:
genes expressing only sense transcripts, genes expressing only anti-
sense transcripts and genes expressing both sense and antisense tran-
scripts. Further a stringent ﬁltering criterion was applied where genes
detected by at least 3 probes were considered for further analysis.
Gene represented by both sense and antisense probes (5330 genes)
representing P. falciparum transcript sequences from PlasmoDBv8.2
were only analyzed and discussed in the paper [9]. Details about the
number and detected transcript type are shown in Table 1. A total of
797 NATs were detected in this study of which 545 were found to be
unique to the study reported in [9].
Discussion
NATs are emerging as a key player in genome regulation. In order to
understand the role, it is necessary to explore their prevalence in the
transcriptome of different organisms including pathogenic ones. Here
we describe the information obtained about the diversity of the NATs
population in P. falciparum clinical isolates from patients with diverse
disease conditions through a 244 K strand-speciﬁc microarray experi-
ment. The detailed analysis of which has been reported recently and is
the ﬁrst in vivo study to describe about the range of NATs that prevails
in P. falciparum clinical isolates [9]. The probes representing the
transcript sequences from PlasmoDBv8.2 were analyzed in detail
in our recent report [9]. However, the array also contains probes
representing the P. falciparum sequences from NCBI database (2012)
detailed here (Supplementary Table S1).
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.gdata.2014.10.010.
Conﬂict of interest
The authors declare that they have no conﬂicts of interest.
Acknowledgements
We thank all the patients and technical workers for their participa-
tion in and support of this project. A.K.S. acknowledges Senior Research
Fellowship from the Council of Scientiﬁc and Industrial Research
(CSIR), New Delhi, India, and Project Assistantship from Department
395A.K. Subudhi et al. / Genomics Data 2 (2014) 393–395of Biotechnology (DBT), New Delhi, India. P.A.B. acknowledges Basic
Scientiﬁc Research fellowship from University Grant Commission,
NewDelhi, India, and Project Assistantship fromDepartment of Biotech-
nology (DBT), New Delhi, India. A.K.D., S.K.K. and D.K.K. acknowledges
Department of Biotechnology (DBT), New Delhi, India for the ﬁnancial
support through the grant BT/PR7520/BRB/10/481/2006 and Birla
Institute of Technology and Science, Pilani, India and S.P. Medical
College, Bikaner, India for providing the required infrastructural
facilities during this study. We thank the PlasmoDB team for making
available the whole genome data and the SAGE data for P. falciparum.
We also thank Genotypic Technology Pvt. Ltd., Bangalore, India, for the
microarray hybridization and preliminary data analysis service provid-
ed by them.
References
[1] C. Aurrecoechea, J. Brestelli, B.P. Brunk, J. Dommer, S. Fischer, B. Gajria, X. Gao, A.
Gingle, G. Grant, O.S. Harb, M. Heiges, F. Innamorato, J. Iodice, J.C. Kissinger, E.
Kraemer, W. Li, J.A. Miller, V. Nayak, C. Pennington, D.F. Pinney, D.S. Roos, C. Ross,
C.J. Stoeckert Jr., C. Treatman, H. Wang, PlasmoDB: a functional genomic database
for malaria parasites. Nucleic Acids Res. 37 (2009) D539–543.
[2] M.J. Gardner, N. Hall, E. Fung, O. White, M. Berriman, R.W. Hyman, J.M. Carlton, A.
Pain, K.E. Nelson, S. Bowman, I.T. Paulsen, K. James, J.A. Eisen, K. Rutherford, S.L.
Salzberg, A. Craig, S. Kyes, M.S. Chan, V. Nene, S.J. Shallom, B. Suh, J. Peterson, S.
Angiuoli, M. Pertea, J. Allen, J. Selengut, D. Haft, M.W. Mather, A.B. Vaidya, D.M.
Martin, A.H. Fairlamb, M.J. Fraunholz, D.S. Roos, S.A. Ralph, G.I. McFadden, L.M.
Cummings, G.M. Subramanian, C. Mungall, J.C. Venter, D.J. Carucci, S.L. Hoffman, C.
Newbold, R.W. Davis, C.M. Fraser, B. Barrell, Genome sequence of the humanmalaria
parasite Plasmodium falciparum. Nature 419 (2002) 498–511.[3] D.K. Kochar, V. Saxena, N. Singh, S.K. Kochar, S.V. Kumar, A. Das, Plasmodium vivax
malaria. Emerg. Infect. Dis. 11 (2005) 132–134.
[4] D.K. Kochar, G.S. Tanwar, P.C. Khatri, S.K. Kochar, G.S. Sengar, A. Gupta, A. Kochar, S.
Middha, J. Acharya, V. Saxena, D. Pakalapati, S. Garg, A. Das, Clinical features of
children hospitalized with malaria—a study from Bikaner, northwest India. Am. J.
Trop. Med. Hyg. 83 (2010) 981–989.
[5] D. Pakalapati, S. Garg, S. Middha, J. Acharya, A.K. Subudhi, A.P. Boopathi, V. Saxena,
S.K. Kochar, D.K. Kochar, A. Das, Development and evaluation of a 28S rRNA gene-
based nested PCR assay for P. falciparum and P. vivax. Pathog. Glob. Health 107
(2013) 180–188.
[6] D. Pakalapati, S. Garg, S. Middha, A. Kochar, A.K. Subudhi, B.P. Arunachalam, S.K.
Kochar, V. Saxena, R.P. Pareek, J. Acharya, D.K. Kochar, A. Das, Comparative
evaluation of microscopy, OptiMAL((R)) and 18S rRNA gene based multiplex PCR
for detection of Plasmodium falciparum & Plasmodium vivax from ﬁeld isolates of
Bikaner, India. Asian Pac. J. Trop. Med. 6 (2013) 346–351.
[7] V. Saxena, S. Garg, S. Ranjan, D. Kochar, A. Ranjan, A. Das, Analysis of elongation
factor Tu (tuf A) of apicoplast from Indian Plasmodium vivax isolates. Infect. Genet.
Evol. 7 (2007) 618–626.
[8] V. Saxena, S. Garg, J. Tripathi, S. Sharma, D. Pakalapati, A.K. Subudhi, P.A. Boopathi,
G.S. Saggu, S.K. Kochar, D.K. Kochar, A. Das, Plasmodium vivax apicoplast genome:
a comparative analysis of major genes from Indian ﬁeld isolates. Acta Trop. 122
(2012) 138–149.
[9] A.K. Subudhi, P.A. Boopathi, S. Garg, S. Middha, J. Acharya, D. Pakalapati, V. Saxena,
M. Aiyaz, H.B. Orekondy, R.C. Mugasimangalam, P. Sirohi, S.K. Kochar, D.K. Kochar,
A. Das, Natural antisense transcripts in Plasmodium falciparum isolates from patients
with complicated malaria. Exp. Parasitol. 141 (2014) 39–54.
[10] R.J. Wilson, P.W. Denny, P.R. Preiser, K. Rangachari, K. Roberts, A. Roy, A. Whyte, M.
Strath, D.J. Moore, P.W. Moore, D.H. Williamson, Complete gene map of the plastid-
like DNA of the malaria parasite Plasmodium falciparum. J. Mol. Biol. 261 (1996)
155–172.
[11] WHO, Severe falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 94 (2000) 1–90.
